Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

Poster Display session 3

1772 - Using Mobile-Based Health Care Applications Outcomes: Mini Systematic Review


30 Sep 2019


Poster Display session 3


Aydanur Aydin


Annals of Oncology (2019) 30 (suppl_5): v816-v821. 10.1093/annonc/mdz272


A. Aydin1, A. GURSOY2

Author affiliations

  • 1 Health Science Institute, Karadeniz Technical University Medical Faculty, 61080 - Trabzon/TR
  • 2 Nursing, Health Science Faculty, 99258 - Cprus/TR


Login to access the resources on OncologyPRO.

If you do not have an ESMO account, please create one for free.

Abstract 1772


The mobile application is a valuable tool in the transmission of information in terms of having easy access in our daily lives and hosting applications containing information specific to many diseases. In a systematic analysis of the studies conducted on smartphones, it was determined that the method of using telephone in two studies was used, six people were reached via message and mobile application was used in five studies.


This systematic review is reported in line with the PRISMA. A total of 24 abstracts were retrieved through a systematic search for articles published in the six databases of PubMed, Cochrane CENTRAL Register of Controlled Trials, Ovid MEDLINE, Science Direct, ULAKBIM Turkish Medical Database, and Google Scholar. Only original resdearch articles included, in having a sample of health related mobile applications.


Twenty four articles were chosen based on the inclusion criteria by researcher. The results of this review related that health related mobile applications. All articles states that health related mobile applications contribute to the individual and plays an important role in health development.


It is determined that researches about mobile health CARE applications in the world should be used in this subject. It can be said that the completed studies are small-sample and very specific, and that large-scale studies with larger samples can contribute significantly to future patient care.

Clinical trial identification

Editorial acknowledgement

Legal entity responsible for the study

Aydanur Aydin.


Has not received any funding.


All authors have declared no conflicts of interest.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.